Caricamento...
PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy
Despite the promise and advantages of autologous cancer cell vaccination, it remains challenging to induce potent anti-tumor immune responses with traditional immunization strategies with whole tumor cell lysate. In this study, we sought to develop a simple and effective approach for therapeutic vac...
Salvato in:
| Pubblicato in: | Biomaterials |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156795/ https://ncbi.nlm.nih.gov/pubmed/30121425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2018.08.016 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|